Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Hims & Hers Health (HIMS)

Hims & Hers issues $1.0 billion of convertible senior notes due 2030

Neutral Impact 4 of 5 financing Written later

Hims & Hers Health issued $1.0 billion of senior, unsecured convertible notes maturing May 15, 2030, under an indenture dated May 13, 2025. The notes carry no regular interest, and the company also entered capped call transactions costing approximately $47.8 million that are expected to reduce potential dilution from conversions.

Key points

  • Notes: $1.0 billion aggregate principal, maturing May 15, 2030; no regular interest accrues
  • Initial conversion price of approximately $70.67 per Class A share; up to 19,455,200 shares issuable on conversion at the maximum rate
  • Capped call cost approximately $47.8 million; cap price initially $89.95 per share, a 75.0% premium over the May 8, 2025 closing price
  • Notes may be redeemed from May 19, 2028 under specified conditions; the company may settle conversions in cash, shares, or both

The filing

CompanyHims & Hers Health (HIMS)
Form8-K, current report
Filed with the SECMay 13, 2025, 5:23 PM ET
Accession number0001193125-25-118948

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation3.02 Unregistered Equity Sale

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 13, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.